| Name | Title | Contact Details |
|---|---|---|
Alex Zelikovsky |
Global Chief Information Officer | Profile |
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
Maxx Orthopedics is a Plymouth Meeting, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medaxial is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Athos is a venture-backed startup developing a revolutionary product for the fitness and athletic market. We are creating next generation wearable technology that gives you real insight into how your body works as you move and combining it with a beautiful user experience that will fit right into your existing routine. Our goal is to empower you to make more informed decisions while pursuing a healthy, active lifestyle.
South Country Health Alliance is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Owatonna, MN. To find more information about South Country Health Alliance, please visit www.mnscha.org